Abukhalil Fawzi, Bodhit Aakash, Cai Peter Y, Ansari Saeed, Thenkabail Spandana, Ganji Sarah, Saravanapavan Pradeepan, Chandra Shekhar Chandana, Waters Michael F, Beaver Thomas M, Shushrutha Hedna Vishnumurthy
Department of Neurology.
Anesthesiology.
J Atr Fibrillation. 2013 Aug 31;6(2):550. doi: 10.4022/jafib.550. eCollection 2013 Aug-Sep.
Atrial fibrillation (AF) has a huge impact on clinical stroke because it is the primary cause of cardio-embolism, which constitutes ~20% of all strokes. As a result, there is a great need to explore safer and more effective primary and secondary prophylactic agents. In this article, we discuss the overlapping issues pertaining to AF from both a neurology and cardiology standpoint. We focus on the dynamic interplay of neurovascular and cardiovascular diseases in relation to AF, traditional and novel risk factors for AF leading to stroke, impact of AF on cognitive decline, and current upstream medical and surgical options for embolism prophylaxis.
心房颤动(AF)对临床中风有巨大影响,因为它是心源性栓塞的主要原因,心源性栓塞约占所有中风的20%。因此,迫切需要探索更安全、更有效的一级和二级预防药物。在本文中,我们从神经学和心脏病学的角度讨论与心房颤动相关的重叠问题。我们关注神经血管疾病和心血管疾病与心房颤动的动态相互作用、导致中风的心房颤动的传统和新危险因素、心房颤动对认知衰退的影响,以及目前预防栓塞的上游医学和手术选择。